Clinical Trial Update: Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir [Phase 3]

View source ↗

Summary

A Phase 3 trial compared once-daily darunavir/ritonavir 800/100 mg with a triple combination darunavir/ritonavir regimen in HIV infection; results were posted o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: HIV Infections, AIDS Virus | Phase 3 | Status: COMPLETED | Results posted: 2010-02-26